Abstract
Majority of patients who experience a Coronary Heart disease event have one or more of the conventional risk factors for atherosclerosis and so do many people who have not yet experienced such an event. Thus predictive models based on conventional risk factors have lower than the desired accuracy, providing a stimulus to search for new factors to predict accurately the risk of CHD. In this regard newer risk factors like homocysteine, Lp(a), insulin resistances are the important ones and are called as ‘novel risk factors’. The study was undertaken to find the prediction of CHD risk by homocysteine in comparison with other conventional risk factors. The data obtained suggests a very high sensitivity, specificity and accuracy with above 90% positive prediction value for homocysteine in CHD patients when compared to commonest conventional risk factors.
Key words: Coronary Artery Disease, homocysteine, Conventional risk factors, Novel Risk factors
Full Text
The Full Text of this article is available as a PDF (64.0 KB).
References
- 1.Knopp RH. Risk factors for Coronary artery disease in women. Am. J. Cardiol. 2002;89(suppl 12A):28E–34E. doi: 10.1016/S0002-9149(02)02409-8. [DOI] [PubMed] [Google Scholar]
- 2.Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J. Factors of risk in the development of coronary heart disease —six year follow up experience: the Framingham Study. Ann. Intern. Med. 1961;55:33–50. doi: 10.7326/0003-4819-55-1-33. [DOI] [PubMed] [Google Scholar]
- 3.Assmann G, Cullen P, Schulte H. Simple scoring for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective cardiovascular Munster (PROCAM) study. Circulation. 2002;105:310–15. doi: 10.1161/hc0302.102575. [DOI] [PubMed] [Google Scholar]
- 4.Iftikar JK, Christie MB. Conditional risk factors for atherosclerosis. Mayo Clin Proc. 2005;80(2):219–30. doi: 10.4065/80.2.219. [DOI] [PubMed] [Google Scholar]
- 5.Fruchart JC, Nierman MC, Stroes ESG, Kastelein JJP, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation. 2004;109(suppl III):III 15–9. doi: 10.1161/01.CIR.0000131513.33892.5b. [DOI] [PubMed] [Google Scholar]
- 6.George NW, Joseph L. Homocysteine and atherothrombosis. NEJM. 1998;338:1042–49. doi: 10.1056/NEJM199804093381507. [DOI] [PubMed] [Google Scholar]
- 7.Chamber's J.C., Obeid O.A., Refsum H., Ueland P., Hackett D., Hooper J., Turner R.M., Thomson S.G., Kooner J.S. Plasma homosysteine concentrations. Lancet. 2000;355:523–27. doi: 10.1016/S0140-6736(99)93019-2. [DOI] [PubMed] [Google Scholar]
- 8.Nair KG, Nair SR, Ashavaid TF, Dalal JJ, Eghlim FF. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in Indian population. JAPI. 2002;50:9–15. [PubMed] [Google Scholar]
- 9.Snehalatha C, Ramachandran A, Satyavani K, Sivasankari S, Sathymurthy I, Viswanathan V. Plasma homocysteine concentration and coronary artery disease in Asian Indian. JAPI. 2002;50:1229–31. [PubMed] [Google Scholar]
- 10.Deepa R, Velumurugan K, Saravanan G, Karkuzhali K, Dwarakanath V, Mohan V. Absence of association between serum homocysteine levels and coronary artery disease in south Indian males. Indian Heart J. 2001;53:44–7. [PubMed] [Google Scholar]
- 11.Alberti KG, Zimmet PZ. Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: Provisional report of a WHO consultation. Diabet Med. 1998;15:539–53. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
- 12.Joint National Committee on detection, evaluation and treatment of high blood pressure. the fifth report. (JNC-V).Arch. Inter. Med 1993; 153: 154–83. [PubMed]
- 13.E'Eramo JL, Finkelstein AE, Boccazi FO, Friedman O. Total homocysteine levels in plasma: high-performance liquid chromatographic determination with electrochemical detection and glassy carbon electrode. J. Of Chromat. B. 1998;720:205–10. doi: 10.1016/S0378-4347(98)00421-6. [DOI] [PubMed] [Google Scholar]
- 14.Sheshadri N, Robinson K. Homocysteine B Vitamin and Coronary artery disease. Med. Clin. North America. 2000;84:215–37. doi: 10.1016/S0025-7125(05)70215-7. [DOI] [PubMed] [Google Scholar]
- 15.McCully KS. Vascular pathology of Homocysteine implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111–28. [PMC free article] [PubMed] [Google Scholar]
- 16.McCully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Arteriosclerosis. 1975;22:215–27. doi: 10.1016/0021-9150(75)90004-0. [DOI] [PubMed] [Google Scholar]
- 17.Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J. Am. Coll. Cardiol. 1996;27:517–27. doi: 10.1016/0735-1097(95)00508-0. [DOI] [PubMed] [Google Scholar]
- 18.Anand SS, Yusuf S, Vuksan V, Devasesan S, Teo KK. Difference in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study if health assessment and risk in ethnic groups (SHARE) Lancet. 2000;356:279–84. doi: 10.1016/S0140-6736(00)02502-2. [DOI] [PubMed] [Google Scholar]
- 19.Sastry BKS, Indira N, Anand B, Kedarnath, Surya Prabha B, Soma Raju B. A case-control study of plasma homocysteine levels in South Indians with or without Coronary artery disease. Indian Heart Journal. 2001;53:749–53. [PubMed] [Google Scholar]
- 20.Boushey CJ, Beresford SA, Omenn GS. A quantitative assessment of Plasma homocysteine as a risk factor for cardiovascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049–57. doi: 10.1001/jama.274.13.1049. [DOI] [PubMed] [Google Scholar]
- 21.Angeline T, Aruna MR, Ramadevi K, Mohan G, Jeyaraj N. Homocysteine status and acute myocardial infarction among Tamilians. IJCB. 2005;20(1):18–20. doi: 10.1007/BF02893035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Neki NS. Hyperhomocysteinemia-An independent risk factor for cardiovascular diseases. JIACM. 2003;4:55–60. [Google Scholar]
- 23.Chacko KA. Plasma homocysteine levels in patients with coronary heart disease. Indian Heart Journal. 1998;50:295–9. [PubMed] [Google Scholar]